- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03604939
Improving Access to Control of Diseases for Women (IMPACD)
August 31, 2021 updated by: International Agency for Research on Cancer
The aim of this study is to evaluate the feasibility and acceptability of the model of delivering CHW-driven home-based comprehensive NCD control services aimed to prevent premature deaths from cardio-vascular diseases, stroke and breast, cervix and oral cancers in the hard-to-reach women.
Study Overview
Status
Completed
Detailed Description
Specific objectives of this study are the evaluation of:
- The social, cultural and behavioral factors that impact the uptake of the NCD control services among rural women using the Rapid Assessment, Response and Evaluation (RARE) approach;
The feasibility and acceptability of the strategy to deliver the following NCD control services to the rural women at their homes by the trained CHWs:
- Counselling of the tobacco habitués to give up the practice
- Early detection of hypertension and diabetes to ensure prompt and regular treatment
- Creating breast awareness and ensuring access to prompt diagnosis and treatment of the women with symptoms suggestive of breast cancer
- Screening for cervical cancer by self-collected HPV test and ensuring prompt treatment of screen detected precancers and cancers
- Screening of the habitual tobacco/alcohol users for oral cancer by OVE and ensuring prompt treatment of screen detected precancers and cancers
Study Type
Interventional
Enrollment (Actual)
1200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rajasthan
-
Udaipur, Rajasthan, India, 313001
- GBH Cancer Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women between 30 to 60 years residing in the villages of the Gogunda block in the district of Udaipur in Rajasthan, India, will be eligible to participate.
Exclusion Criteria:
- Women suffering from debilitating illnesses, pregnant women and women refusing to participate will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outcomes of the questionnaire survey 1/5
Time Frame: 1 year
|
proportion of the participants who know about the adverse effect of smoking, chewing tobacco and consuming alcohol on health in general and NCDs in particular
|
1 year
|
Outcomes of the questionnaire survey 2/5
Time Frame: 1 year
|
proportion of the participants who know about the common NCDs including cancers and their early symptoms
|
1 year
|
Outcomes of the questionnaire survey 3/5
Time Frame: 1 year
|
proportion of the participants with a diagnosis of hypertension who adhere to the treatment advised
|
1 year
|
Outcomes of the questionnaire survey 4/5
Time Frame: 1 year
|
proportion of the participants with a diagnosis of diabetes who adhere to the treatment advised
|
1 year
|
Outcomes of the questionnaire survey 5/5
Time Frame: 1 year
|
proportion of the participants with a diagnosis of cancer who adhere to the treatment advised
|
1 year
|
NCD Screening study 1/11
Time Frame: 1 year
|
screen positivity - proportion of the screened participants detected to have high blood pressure
|
1 year
|
NCD Screening study 2/11
Time Frame: 1 year
|
screen positivity - proportion of the screened participants detected to have high BMI
|
1 year
|
NCD Screening study 3/11
Time Frame: 1 year
|
screen positivity - proportion of the screened participants detected to have abnormal HPV detection test
|
1 year
|
NCD Screening study 4/11
Time Frame: 1 year
|
screen positivity - proportion of the screened participants detected to have abnormal oral examination test
|
1 year
|
NCD Screening study 5/11
Time Frame: 1 year
|
screen positivity - proportion of the screened participants detected to have abnormal visual examination test
|
1 year
|
NCD Screening study 6/11
Time Frame: 1 year
|
compliance to further assessment - proportion of screen positive participants undergoing further assessment at the primary health center or at the hospital
|
1 year
|
NCD Screening study 7/11
Time Frame: 1 year
|
positive predictive values of further assessment - proportion of participants with confirmed diagnosis of hypertension among those assessed for high BP
|
1 year
|
NCD Screening study 8/11
Time Frame: 1 year
|
positive predictive values of further assessment - proportion of participants with confirmed diabetes among those assessed for high sugar
|
1 year
|
NCD Screening study 9/11
Time Frame: 1 year
|
positive predictive values of further assessment - proportion of participants with confirmed cervical neoplasias on colposcopy and/or biopsy among those assessed for positive HPV test
|
1 year
|
NCD Screening study 10/11
Time Frame: 1 year
|
positive predictive values of further assessment - proportion of participants with confirmed oral premalignant and malignant lesions on examination and/or biopsy among those assessed for positive oral examination
|
1 year
|
NCD Screening study 11/11
Time Frame: 1 year
|
positive predictive values of further assessment - proportion of participants with confirmed visual premalignant and malignant lesions on examination and/or biopsy among those assessed for positive visual examination
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
effect of different participant characteristics on the final diagnosis of hypertension and diabetes using multivariate analysis
Time Frame: 1 year
|
effect of different participant characteristics on the final diagnosis of hypertension and diabetes using multivariate analysis
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Mahajan M, Naik N, Jain K, Patira N, Prasad S, Mogri S, Muwonge R, Lucas E, Faruq F, Sankaranarayanan R, Iyer S, Basu P. Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India. J Glob Oncol. 2019 Apr;5:1-10. doi: 10.1200/JGO.18.00181.
- Basu P, Mahajan M, Patira N, Prasad S, Mogri S, Muwonge R, Lucas E, Sankaranarayanan R, Iyer S, Naik N, Jain K. A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India. BMC Public Health. 2019 Jan 3;19(1):14. doi: 10.1186/s12889-018-6350-4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
August 1, 2018
Study Completion (Actual)
July 1, 2019
Study Registration Dates
First Submitted
August 17, 2017
First Submitted That Met QC Criteria
July 20, 2018
First Posted (Actual)
July 30, 2018
Study Record Updates
Last Update Posted (Actual)
September 5, 2021
Last Update Submitted That Met QC Criteria
August 31, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DCA/SCR/2016/01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Cancer
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingCervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Stage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IA1 Cervical Cancer | Stage IA2 Cervical Cancer | Stage IB1 Cervical Cancer | Stage IB2 Cervical Cancer | Stage IB3 Cervical CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Stage IIIA Cervical Cancer | Stage IIIB Cervical CancerUnited States
-
Shanghai First Maternity and Infant HospitalNot yet recruitingCervical Cancer, Stage IIB | Cervical Cancer Stage IIIB | Cervical Cancer Stage IIIA | Cervical Cancer, Stage IVA
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical CancerUnited States
-
Institut de Cancérologie de LorraineCompletedCervical Adenocarcinoma | Stage IB Cervical Cancer | Stage III Cervical Cancer | Stage II Cervical CancerFrance
Clinical Trials on Evaluation of social, cultural and behavioral factors
-
University Rovira i VirgiliCompletedCardiovascular Diseases | Quality of Life
-
University of Mississippi Medical CenterRecruitingBreastfeeding | Breastfeeding, ExclusiveUnited States
-
Universitaire Ziekenhuizen KU LeuvenBelgian GovernmentCompletedSedentary LifestyleBelgium
-
University of BolognaUnknownHealth Behavior | Personal Satisfaction
-
St. Jude Children's Research HospitalM.D. Anderson Cancer Center; National Institute of Mental Health (NIMH)CompletedAcute Lymphoblastic Leukemia | Neurocognitive ImpairmentUnited States
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
East Carolina UniversityRecruiting
-
Abramson Cancer Center at Penn MedicineGilead SciencesRecruitingBreast Cancer | Social Determinants of Health (SDOH)United States